Pragmatic management of acute cough in children and adolescents an updated position paper by the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Main Article Content
Keywords
Abstract
Background: Cough is one of the most common and distressing symptoms in pediatric practice and represents a major cause of medical consultation, parental anxiety, and inappropriate medication use. Although most acute cough episodes are benign and self-limiting, they can significantly affect child’s sleep, school performance, and quality of life. The COVID-19 pandemic and subsequent changes in infection patterns and immune responses have further highlighted the need to update the existing clinical guidance.
Objective: This joint position paper by the Italian Society of Pediatric Allergy and Immunology (SIAIP) aims to provide a pragmatic, evidence-based update on the management of acute and post-viral cough in children and adolescents, integrating recent scientific advances and real-world clinical experiences.
Methods: A multidisciplinary board of experts from SIAIP critically reviewed the literature published from 2019 to 2025 and updated the previous 2019 SIAIP document. The group achieved consensus on diagnostic and therapeutic recommendations through structured discussion and iterative revision.
Results: The document emphasizes a stepwise approach to pediatric acute cough, starting with careful history-taking, clinical evaluation, and reassurance. Non-pharmacological measures—hydration, nasal saline irrigation, and avoidance of irritants—remain the first-line management. Pharmacological therapy may be considered in selected cases where cough is particularly distressing or significantly interferes with sleep; peripherally acting, nonsedative antitussives represent a reasonable option in terms of efficacy and safety. Centrally acting antitussives and unnecessary antibiotics should be avoided. Standardized, high-quality natural medical devices—with appropriate supporting evidence—represent a valid option. Honey-based preparations can be considered as complementary options. The paper also discusses new insights into cough pathophysiology, particularly the role of airway sensory hypersensitivity and neurogenic inflammation, which are paving the way for mechanism-based treatments.
Conclusions: This position paper provides an updated, pragmatic framework for the management of acute and post-viral cough in children and adolescents. It promotes rational drug use, integration of non-pharmacological and complementary measures, and awareness of emerging therapeutic targets. A mechanism-driven, individualized, and family-centered approach is advocated to improve clinical outcomes and quality of life for pediatric patients.
References
2. Marseglia GL, Manti S, Chiappini E, Brambilla I, Caffarelli C, Calvani M, et al. Acute cough in children and adolescents: A systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology. Allergologia Immunopathol. 2021;49(2):155–69. https://doi.org/10.15586/aei.v49i2.44
https://doi.org/10.15586/aei.v49i2.45
3. Brodlie M, Graham C, McKean MC. Childhood cough. BMJ. 2012;344:e1177. https://doi.org/10.1136/bmj.e1177
4. Chang AB. Pediatric cough: Children are not miniature adults. Lung 2010;188(Suppl 1):S33–40. https://doi.org/10.1007/s00408-009-9166-2
5. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006;129:1S–23. https://doi.org/10.1378/chest.129.1_suppl.1S
6. Marchant JM, Newcombe PA, Juniper EF, Sheffield JK, Stathis SL, Chang AB. What is the burden of chronic cough for families? Chest 2008;134:303–9. https://doi.org/10.1378/chest.07-2236
7. Manti S, Tosca MA, Licari A, Brambilla I, Foiadelli T, Ciprandi G, et al. Cough remedies for children and adolescents: Current and future perspectives. Paediatr Drugs. 2020;22(6):617–34. https://doi.org/10.1007/s40272-020-00420-4
8. Ciprandi G, Tosca MA. Non-pharmacological remedies for post-viral acute cough. Monaldi Arch Chest Dis. 2021;92(1):monaldi.2021.1821. https://doi.org/10.4081/monaldi.2021.1821
9. Leontari K, Lianou A, Tsantes AG, Filippatos F, Iliodromiti Z, Boutsikou T, et al. Pertussis in early infancy: Diagnostic challenges, disease burden, and public health implications amidst the 2024 resurgence, with emphasis on maternal vaccination strategies. Vaccines (Basel). 2025;13(3):276. https://doi.org/10.3390/vaccines13030276
10. Rao S, Gross RS, Mohandas S, Stein CR, Case A, Dreyer B, et al. Postacute sequelae of SARS-CoV-2 in children. Pediatrics. 2024;153(3):e2023062570. https://doi.org/10.1542/peds.2023-062570
11. Oesterle TS, Kolla B, Risma CJ, Breitinger SA, Rakocevic DB, Loukianova LL, et al. Substance use disorders and telehealth in the COVID-19 pandemic era: A new outlook. Mayo Clin Proc. 2020;95(12):2709–18. https://doi.org/10.1016/j.mayocp.2020.10.011
12. Lacombe A, Quintela I, Liao YT, Wu VCH. Food safety lessons learned from the COVID-19 pandemic. J Food Saf. 2021;41(2):e12878. https://doi.org/10.1111/jfs.12878
13. Assi M, Abbas S, Nori P, Doll M, Godbout E, Bearman G, et al. Infection prevention and antimicrobial stewardship program collaboration during the COVID-19 pandemic: A window of opportunity. Curr Infect Dis Rep. 2021;23(10):15. https://doi.org/10.1007/s11908-021-00759-w
14. Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322(1):C1–11. https://doi.org/10.1152/ajpcell.00375.2021
15. Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P. COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Sci Prog. 2021;104(2):368504211019854. https://doi.org/10.1177/00368504211019854
16. Murgia V, Ciprandi G, Votto M, De Filippo M, Tosca MA, Marseglia GL. Natural remedies for acute post-viral cough in children. Allergol Immunopathol (Madr). 2021;49(3):173–84. https://doi.org/10.15586/aei.v49i3.71
17. Ciprandi G. Natural anti-tussive products for children and adolescents: Darkness and shadow. Minerva Pediatr (Torino). 2025 (in press). https://doi.org/10.23736/S2724-5276.25.07848-6
18. Cox JK, Lockey R, Cardet JC. Cough-variant asthma: A review of clinical characteristics, diagnosis, and pathophysiology. J Allergy Clin Immunol Pract. 2025;13(3):490–8. https://doi.org/10.1016/j.jaip.2024.11.005
19. Galway NC, Shields MD. The child with an incessant dry cough. Paediatr Respir Rev. 2019;30:58–64. https://doi.org/10.1016/j.prrv.2018.08.002
20. Liu NM, Chadwick CL, Gupta A. Habit cough in children. Paediatr Child Health. 2023; 23(4):85–118. https://doi.org/10.1016/j.paed.2023.01.004
21. Gilchrist FJ. An approach to the child with a wet cough. Paediatr Respir Rev. 2019;31:75–81. https://doi.org/10.1016/j.prrv.2018.11.002
22. Kantar A, Chang AB, Shields MD, et al. ERS statement on protracted bacterial bronchitis in children. Eur Respir J. 2017;50(2):1602139. https://doi.org/10.1183/13993003.02139-2016
23. Bisballe-Müller N, Chang AB, Plumb EJ, Oguoma VM, Halken S, McCallum GB. Can acute cough characteristics from sound recordings differentiate common respiratory illnesses in children?: A comparative prospective study. Chest. 2021;159(1):259–69. https://doi.org/10.1016/j.chest.2020.06.067
24. Marseglia GL, Veraldi D, Ciprandi G. Management of children with acute post-viral cough: A primary care experience with levodropropizine. Minerva Pediatr (Torino). 2025;77(4):281–7. https://doi.org/10.23736/S2724-5276.24.07691-2
25. Ciprandi G, Nutraceutical and Medical Device Task Force of the Italian Society of Pediatric Allergy, Immunology (SIAIP). Natural anti-tussive products for children and adolescents: Darkness and shadow. Minerva Pediatr (Torino). Published online June 13, 2025. https://doi.org/10.23736/S2724-5276.25.07848-6
26. Marseglia GL, Ciprandi G. Levodropropizine for children and adolescents with acute post-viral cough: An evidence-based choice. Minerva Pediatr (Torino). 2024;76(6):758–66. https://doi.org/10.23736/S2724-5276.24.07638-9
27. Suyo MM, Covington C. An unusual case of chronic cough in a pediatric patient. Ann Allergy Asthma Immunol. 2022;129(5):S160–1. https://doi.org/10.1016/j.anai.2022.08.974
28. Murgia V, Manti S, Licari A, De Filippo M, Ciprandi G, Marseglia GL. Upper respiratory tract infection-associated acute cough and the urge to cough: New insights for clinical practice. Pediatr Allergy Immunol Pulmonol. 2020;33(1):3–11. https://doi.org/10.1089/ped.2019.1135
29. Bonvini SJ, Belvisi MG. Cough and airway disease: The role of ion channels. Pulm Pharmacol Ther. 2017;47:21–8. https://doi.org/10.1016/j.pupt.2017.06.009
30. Mazzone SB, Undem BJ. Vagal afferent innervation of the airways in health and disease. Physiol Rev. 2016;96(3):975–1024. https://doi.org/10.1152/physrev.00039.2015
31. Smith JA, Kitt MM, Morice AH, et al. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: A randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med. 2020;8(8):775–85. https://doi.org/10.1016/S2213-2600(19)30471-0
32. Grace MS, Bonvini SJ, Belvisi MG, McIntyre P. Modulation of the TRPV4 ion channel as a therapeutic target for disease. Pharmacol Ther. 2017;177:9–22. https://doi.org/10.1016/j.pharmthera.2017.02.019
33. Canciani M, Murgia V, Caimmi D, Anapurapu S, Licari A, Marseglia GL. Efficacy of Grintuss pediatric syrup in treating cough in children: A randomized, multicenter, double blind, placebo-controlled clinical trial. Ital J Pediatr. 2014;40:56. https://doi.org/10.1186/1824-7288-40-56
34. Cohen HA, Hoshen M, Gur S, Bahir A, Laks Y, Blau H. Efficacy and tolerability of a polysaccharide-resin-honey based cough syrup as compared to carbocysteine syrup for children with colds: A randomized, single-blinded, multicenter study. World J Pediatr 2017;13(1):27–33. https://doi.org/10.1007/s12519-016-0048-4